Delivery Order 36F79724D0201-36C24424F0564

Award Date 9/13/24
Potential Completion Date 9/12/26
Potential Value $2.7M
Ultimate Awardee
Abbott Laboratories
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Des Plaines, IL 60018, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price delivery order to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide a molecular diagnostic testing system. The contract is valued at $606,774.20 and was awarded on December 1, 2019, with a completion date of November 30, 2021. The contract was issued under the VA's Veterans Integrated Service Network 21 and did not utilize a set-aside designation. As a large pharmaceutical and...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $354,218.93 firm fixed price purchase order to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for COVID-19 reagents and supplies under the Alinity-M testing platform. This order was placed by the VA Veterans Integrated Service Network 2, which covers facilities in New York and New Jersey. Abbott Molecular is a medical device manufacturer that has provided a range of diagnostic tests, equipment, and...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 awarded a $882,490 firm fixed price purchase order to Abbott Molecular Inc., a division of Abbott Laboratories, to provide Alinity M supplies for COVID-19 testing. The contract supports the VA's response to the Coronavirus pandemic through the procurement of molecular diagnostic testing materials from the prime contractor's Des Plaines, Illinois location. Abbott Molecular will deliver its...
The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price delivery order to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide COVID-19 testing equipment, molecular analyzers, and reagents. The order is under the Veterans Integrated Service Network 15 and has a potential value of $747,456.06 with an end date of October 14, 2023. This delivery order is part of a Blanket Purchase Agreement (BPA) call under the GSA Schedule 65-VII contract...
This is a federal contract award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, by the Veterans Integrated Service Network 2 (VISN 2) of the U.S. Department of Veterans Affairs. The $118,095.28 contract is for the provision of nucleic acid and SARS testing services and supplies, including molecular diagnostic equipment, reagents, and test kits. The contract is a Blanket Purchase Agreement (BPA) call and is structured as a firm fixed-price arrangement. This award is not set...
This is a $2,881,207.90 firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 7, a civilian agency under the Department of Veterans Affairs, to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The contract is for the provision of Alinity M chemistry analyzers, which are advanced molecular diagnostic instruments used for comprehensive testing of infectious diseases, sexually transmitted infections, and other medical conditions. The contract is...
This is a federal contract award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, by the Department of Veterans Affairs (VA). The contract, awarded on September 29, 2017, is for the provision of molecular diagnostics products and services, including COVID-19 test kits, reagents, and viral load testing. The contract has a ceiling value of $86,103.31 and an ultimate completion date of March 8, 2022. This award is not set aside for small businesses. Abbott Molecular Inc. is an...
This federal contract award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, is for the provision of Infectious Disease PCR Reagents and Consumables. The contract, valued at $6,665,247.19, is a Delivery Order awarded on March 14, 2022, with a completion date of September 30, 2026. It is a Firm Fixed Price contract funded by the Veterans Integrated Service Network 8, a civilian agency within the Department of Veterans Affairs. The contract does not utilize a set-aside designation,...
This federal contract award, valued at $718,564.83, was made by the Veterans Integrated Service Network 1 (VISN 1), a division of the U.S. Department of Veterans Affairs (VA), to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The contract is a Blanket Purchase Agreement (BPA) call for the provision of Alinity M COVID-19 testing, HIV testing, and human papillomavirus (HPV) testing supplies. The contract has a firm fixed price pricing type and a completion date of September 21,...
This is a contract award to Abbott Molecular Inc., a subsidiary of the pharmaceutical company Abbott Laboratories, by the Department of Veterans Affairs (VA) Veterans Health Administration. The $1,571,827.99 contract is a Blanket Purchase Agreement (BPA) call order under the VA's GSA Schedule 65-VII contract for in vitro diagnostics, reagents, and tests. The contract is for the supply of COVID-19 testing equipment and molecular analyzers to the VA, without the need for sample aliquoting. This...

This firm-fixed-price delivery order contract, awarded by the Veterans Integrated Service Network 4, provides the Department of Veterans Affairs (VA) with all supplies related to sexually transmitted infection (STI) and SARS-CoV-2 testing on the Alinity M platform. The $2,683,875.95 contract was awarded to Abbott Molecular Inc., a subsidiary of the global healthcare company Abbott Laboratories, on September 13, 2024, with a completion date of September 12, 2026. The contract is not designated as a set-aside. Abbott Molecular Inc. is the prime contractor and will be providing the VA with molecular diagnostic equipment, reagents, test kits, and related services for comprehensive infectious disease testing. This contract is part of several indefinite delivery vehicles (IDVs) and blanket purchase agreements (BPAs) that Abbott Molecular has secured with the VA, allowing the agency to rapidly procure critical testing materials and equipment, particularly during the COVID-19 pandemic.

Generated 9/9/25, 12:46 PM